Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) [Phase 3]
A Phase 3 clinical trial evaluating tarlatamab after chemoradiotherapy in limited-stage small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer [Phase 2]
This Phase 2 trial is evaluating the optimal dose, adverse events, and changes in disease activity of ABBV-706 in combination with atezolizu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
A clinical trial update indicates ongoing recruitment for a study evaluating cardiopulmonary exercise testing in lung cancer patients before…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: PF-07104091 as a Single Agent and in Combination Therapy [Phase 2]
Pfizer's PF-07104091 is being studied as a single agent and in combination therapy in Phase 2 trials for small cell lung cancer, ovarian can…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating investigational agents as monotherapy or in combination with pembrolizumab for second-line treatment o…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer [Phase 1]
This entry describes an ongoing Phase 1 clinical trial evaluating tazemetostat in combination with topotecan and pembrolizumab for recurrent…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update compares atezolizumab following concurrent chemoradiotherapy to chemoradiotherapy alone in limited-disease s…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003) [Phase 1, Phase 2]
This clinical trial update reports the ongoing Phase 1/Phase 2 study MK-6070-003 evaluating Gocatamig (MK-6070) and Infinatamab Deruxtecan (…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
This is a Phase 1 trial updating the safety and dosing of M6620 in combination with irinotecan in patients with metastatic or unresectable s…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial of the DLL3-targeting radiopharmaceutical [212Pb]Pb-DOTAM-MAM279 (MP0712) in small cell lung cancer and other DLL…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of temozolomide and atezolizumab for second-line treatment of metastatic or recurrent smal…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors [Phase 1]
This clinical trial update reports a Phase 1 dose-determining study of EXS74539 (REC-4539) in participants with select solid tumors, current…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase I study of SYS6043 in patients with advanced or metastatic solid tumors is currently recruiting, including prostate cancer, small cell…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy [NA]
A clinical trial update comparing single-dose versus multiple-dose radiation in cancer patients with brain metastases who are receiving immu…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab
A clinical-trial update presenting real-world data on using the immune-checkpoint inhibitor tislelizumab to treat lung cancer, with recruiti…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of serplulimab plus chemotherapy in small-cell lung cancer that has transform…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of ZL-1310 in Subjects With Small Cell Lung Cancer [Phase 1]
This is a Phase 1 clinical trial update for ZL-1310 in patients with small cell lung cancer, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients [NA]
Clinical trial update about an MDT-based umbrella decision model for geriatric lung cancer patients; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the 68Ga-PFD3 PET imaging tracer for diagnosing and evaluating small cell lung cancer, currently recru…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer [Phase 3]
A Phase 3 clinical trial is assessing whether immunonutrition can reduce acute esophagitis in patients with lung cancer undergoing thoracic …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 [Phase 1]
Phase 1 study evaluating tolerability of different doses of Obrixtamig (BI 764532) in combination with Ezabenlimab in patients with small ce…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: SKB500 Combinations in Patients With Small Cell Lung Cancer [Phase 2]
An ongoing Phase 2 clinical trial evaluating SKB500 in combination regimens for patients with Small Cell Lung Cancer.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
ClinicalTrials.gov shows an observational study named Sculptor conducted by Tempus AI investigating Small cell lung cancer. The study is cur…